Invention Grant
- Patent Title: Methods employing circulating DNA and miRNA as biomarkers for female infertility
-
Application No.: US16447221Application Date: 2019-06-20
-
Publication No.: US10731218B2Publication Date: 2020-08-04
- Inventor: Samir Hamamah , Sabine Traver , Elodie Scalici
- Applicant: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) , UNIVERSITE DE MONTPELLIER , CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER
- Applicant Address: FR Paris FR Montpellier FR Montpellier
- Assignee: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE),UNIVERSITE DE MONTPELLIER,CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER
- Current Assignee: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE),UNIVERSITE DE MONTPELLIER,CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER
- Current Assignee Address: FR Paris FR Montpellier FR Montpellier
- Agency: W&C IP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@3420f7d1
- Main IPC: C12Q1/6883
- IPC: C12Q1/6883 ; G16H10/60
Abstract:
The present invention relates generally to the fields of reproductive medicine. More specifically, the present invention relates to methods for determining the ovarian reserve and ovarian function by determining the level of cell-free nucleic acids or the level of a miRNA species selected from miR_30_a or miR_140 or let_7_b or miR_191 or miR_320_a or miR_21 or miR_30_d or miR_574_3p. The method may also be used in predicting the efficacy of controlled ovarian hyperstimulation.
Public/Granted literature
- US20190367987A1 METHODS EMPLOYING CIRCULATING DNA AND MIRNA AS BIOMARKERS FOR FEMALE INFERTILITY Public/Granted day:2019-12-05
Information query
